$97.510
-0.887 (-0.91%)At close
MANE Comparative Benchmarking
In the context of the broader market, MANE competes directly with industry leaders such as INDV and BDRX. With a market capitalization of $4.71B, it holds a leading position in the sector. When comparing efficiency, MANE's gross margin of N/A stands against INDV's 85.42% and BDRX's N/A. Such benchmarking helps identify whether Veradermics, Incorporated is trading at a premium or discount relative to its financial performance.
Veradermics Inc Financial Performance
The company has shown a significant increase in total equity, rising from 39,064,000 USD in Q1 2026 to 81,361,300 USD in Q2 2026, indicating improving financial stability despite ongoing losses.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.